IntroduCtIon
In 2015, the Government of Malawi committed to the Joint United Nations Programme on
Key questions
What is already known about this topic?
► Numerous studies have explored progress towards the Joint United Nations Programme on HIV/AIDS 90-90-90 targets, which could be framed as an HIV-oriented extension of the universal health coverage movement as they focus on quality across the HIV care continuum. ► However, these studies rely on infrequent and population-based surveys, and there is a need for a more practical approach to programme monitoring. ► Many studies have advocated for HIV programmes to include comprehensive services, such as community health workers and different forms of psychosocial and economic support, but evaluations of comprehensive programmes with these components are limited.
What are the new findings?
► Our study suggests that HIV programmes focusing on social determinants of health, community health workers and direct support to ministries of health may increase survival and retention for patients with HIV. ► We also introduce a practical approach for programme monitoring, using components aligned with the 90-90-90 targets.
recommendations for policy ► As governments strive towards achieving the 90-90-90 targets and universal health coverage, it is worth considering policies integrating HIV programming in primary healthcare via support of the public sector and strong community footprints, and adopting approaches that address basic health systems needs and the social determinants of health.
BMJ Global Health
HIV/AIDS (UNAIDS) goal known as 90-90-90: 90% of HIV-positive patients diagnosed, 90% of those diagnosed sustained on treatment and 90% of those on treatment achieving viral suppression-all by 2020. 1 However, robustly measuring progress towards these targets relies on expensive and infrequent population-based surveys, which may not always be practical for local programmes or in routine service delivery settings. 2 Given the recognition that achieving 90-90-90 will require a health system strengthening approach involving local governments and civil society partners, there is a need for a more practical, programme-oriented approach for local monitoring. 3 The 90-90-90 targets can help programmes measure success and make targeted improvements to HIV services in the spirit of achieving universal health coverage (UHC), 4 given the focus on providing high-quality care for every patient with HIV in a given population.
Malawi's pursuit of 90-90-90 is particularly important given the context: it is one of only nine countries with HIV prevalence exceeding 9%, and in 2015 only half of those affected were receiving treatment-approximately 500 000 people. 5 6 As a landlocked, mountainous country with limited supply chains and infrastructure, and having severe resource constraints commensurate with the fourth lowest gross domestic product (GDP) per capita in the world, acquisition and distribution of antiretroviral therapy (ART) to these individuals are highly challenging. 7 8 However, Malawi has progressive policies, clear commitment and strong central leadership in the HIV programme: Malawi was the first country to initiate Option B+, placing all HIV-positive pregnant women on ART, regardless of CD4 count. 9 In 2016, the national HIV programme adopted the WHO recommendations for universal treatment. 10 One study by Medecins sans Frontieres in Chiradzulu District in southern Malawi showed that a high level of population viral suppression is possible in this setting.
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Working towards 90-90-90 targets requires both national commitment as well as innovation in service delivery. Throughout the AIDS epidemic, multiple approaches and debates have been advanced as a means to achieve ART coverage and epidemic control, including those highlighting the tension between HIV integration within primary care versus more vertical HIV interventions, and facility-oriented versus community-oriented models. 12 For the latter, many community-based programmes have used community health workers (CHWs) to increase retention in care for HIV-positive adults and children and HIV-exposed infants. [13] [14] [15] [16] [17] In addition, economic support to offset treatment costs and address underlying poverty has been put forward in the form of cash transfers, and programmes including food packages have shown higher rates of adherence. [18] [19] [20] [21] Since 2007, Partners In Health (PIH) and the Malawi Ministry of Health (MOH) have been collaborating in one of the country's poorest districts-Neno District-to implement an innovative HIV/AIDS service delivery model, grounded in decentralised care and a strong community footprint. [22] [23] [24] This programme is founded on a long history of PIH's work in partnership with governments and communities globally. 12 25 26 An extensive literature demonstrates that a community-based service delivery platform employing CHWs is effective in providing patients with psychosocial accompaniment, adherence support, longitudinal follow-up and missed visit tracking. [27] [28] [29] [30] It also addresses social determinants of disease-meaning social and economic conditions that can influence differences in health status-as part of a comprehensive package. 27 28 Furthermore, to promote sustainability, the model is integrated within the Malawi MOH systems to strengthen primary healthcare, an approach that has also been used in Haiti and Rwanda. 12 25 In this manuscript, we characterise the HIV care continuum in Neno District, and compare facility-level HIV outcomes between the Neno programme and all other health facilities nationally to estimate impact. Specifically, we describe programme performance over a 3-year period (2013) (2014) (2015) according to the 90-90-90-aligned outcomes along the HIV care continuum, comparing outcomes from Neno District facilities with all other Malawian facilities. We describe the results for HIV screening, enrolment, retention and survival, describing outcomes over time to interrogate consistency and robustness of observed effects to secular trends. We also describe our programme practices and interventions, which encompass establishing a strong community footprint, addressing the social determinants of health and advancing true partnerships with the public sector. 31 It represents one of the poorest and most rural districts in the country, with no tarmac roads, the majority of the population relying on subsistence agriculture and only 3.7% having electricity. 32 For our study, we included all 13 health facilities in Neno District, including 1 district hospital, 1 community hospital and 11 primary health centres, all of which have been providing free HIV care since 2011. For the comparative analysis, we included all facilities in Malawi providing HIV care, comprising 29 districts and 682 facilities-which, including Neno, represents over 4 800 000 HIV screening events and 370 000 new ART enrolments. In Malawi, 84% of the population is rural. 31 neno HIV programme design The novelty of the Neno District HIV programme resides in three core principles, each rooted in the concept of accompaniment-or supporting the entirety of needs of the patient-with a focus on delivering services in a BMJ Global Health community-oriented way with the intention to reduce structural barriers to successful treatment: During 2013-2015, national policy mandated all HIV-positive patients with CD4 ≤500 cells/mm 3 or WHO stage 3 or 4 (regardless of CD4 count) be enrolled in ART, in addition to all HIV-positive pregnant women and children under 5 years confirmed HIV-positive. 34 Thus, the following were the study inclusion criteria: (1) a positive diagnosis of HIV and (2) enrolment in the national ART programme between 1 January 2013 and 30 December 2015. All facilities outside Neno providing HIV care in Malawi during this time period were chosen as comparison facilities. Fidelity to enrolment protocols and quality of data were monitored both centrally during quarterly MOH supervision at the facility level and through routine data validation. 35 
MetHods

Measures
We developed HIV programme performance metrics aligned with the UNAIDS 90-90-90 targets 36 that evaluated finding, enrolling and achieving high-quality outcomes in both known and undiagnosed expected patients with HIV in a given adult population. Thus, for case finding, we evaluated the number of total HIV tests performed in a district for those aged >15 years, over the course of a year, represented as relative to the number of individuals over the age of 15 in the catchment area. For successful enrolments, we measured the per cent of the catchment population newly enrolled in HIV care on an annual basis among those expected to be HIV-positive based on district population prevalence. 37 For both metrics, the number of new screenings and new enrollees was selected, rather than cumulative total, in order to measure district-level improvement in the care continuum over time. However, in districts that were closer to achieving these targets at baseline, it is likely that screenings and enrolments decelerate-as new HIV-positive individuals become harder to find and enrol. Thus, we also report on the proportion achieved for anticipated full enrolment and the yield of HIV testing for Neno and nationally. We used the highest estimate of 1 100 000 expected people living with HIV (PLHIV) in Malawi in 2015 and applied district-level HIV prevalence estimates from the 2015-2016 Demographics and Health Survey. 32 For the quality and success of treatment, in place of viral suppression used for the third 90, we elected to measure the average 1-year survival and retention rates at the facility level within districts. In many sub-Saharan African contexts, including Malawi, viral load results are not routinely available-largely because this depends on testing and supply chain systems for which a majority of facilities are not yet equipped. This limitation in routine viral load results includes Neno until system improvements and GeneXpert testing were introduced in late 2016. In such contexts, quality of care can be more broadly assessed in terms of patient survivorship and their routine return to facilities to acquire medicines to continue treatment.
BMJ Global Health statistical analysis
We examined statistical power to detect a medium effect size (δ=0.50) when comparing facility-level trends within Neno district versus all facilities throughout all other districts, over a 3-year period. Assuming a standard α level of 0.05, a sample of 682 facilities, intracluster correlation coefficient for district-level clustering of <0.05 and serial correlation of r=0.50, statistical power was greater than 80% to detect the effect size of interest.
We used mixed-effects, multilevel models to evaluate HIV outcomes across districts and to compare performance in Neno District versus all other districts. Random effects were incorporated for facilities and districts, whereby facilities were nested within districts and districts were nested within years. Fixed effects were included for Neno District and for specific years, in order to examine change in 2014 and 2015, relative to the baseline year of 2013. The interaction term of interest was Neno × year, which examined whether change over time on outcomes of interest was greater in Neno District compared with other districts. As a secondary set of analyses, we incorporated two sets of demographic district-level covariates: namely, the percentage of individuals in the district who are female and the percentage of households with electricity-as a proxy for district-level wealth, taken from the 2015-2016 Demographics and Health Survey. 32 Neither covariate had any substantive impact on the results. We therefore chose to report primary models throughout in order to aid interpretability. Analyses were conducted in STATA V.13.0 SE.
Patient involvement
This was an observational study, and patients were not involved in the study design. results descriptive characteristics of sample From January 2013 through December 2015, 4 869 503 screenings for HIV were performed at facilities throughout Malawi. Over this same period, 368 046 individuals aged 15 and over were newly enrolled in the HIV programme. The average 1-year survival among new ART enrollees at the facility level was 79.5%, and the per cent retained in care at 1 year was 83.9%. Table 1 presents an overview of this information at the district level on an annual basis.
Performance over time Case finding
At baseline in 2013, the estimated proportion of the adult population who underwent HIV testing at a health facility was 11.75% (P<0.001, 95% CI 10.53% to 12.96%). This was 3.94% higher in Neno District (15.69%), but the difference was not statistically significant (P=0.24, 95% CI −2.61% to 10.49%). Over the 3-year period, the average per cent of the population in all districts receiving HIV screening increased by 4.23% (P<0.001, 95% CI 2.98% to 5.49%). This trend towards improvement over time was not significantly different in Neno (P=0.52, 95% CI −8.98% to 4.52). The yield of HIV testing in Neno was different from the yield nationally: Over the 3-year period, the national positivity rate among screenings was 6.91% (P<0.001, 95% CI 5.84% to 7.98%); this was 1.35% lower in Neno District (P=0.01, 95% CI −2.42% to −0.29%). Table 2 shows these outcomes by district over the 3-year period.
Enrolments
In 2013, the average per cent of total expected HIV-positive adults (ages 15 and over) who were newly enrolled in ART during that year-based on national HIV prevalence-was 12.42% (P<0.001, 95% CI 10.54% to 14.30%). New enrolment levels were not significantly higher in Neno District (P=0.56, 95% CI −13.12% to 7.13%). From 2013 to 2015, annual enrolment levels did not change nationally (P=0.17, 95% CI −0.22% to 1.74%). This trend was similar in Neno District (P=0.78, 95% CI −3.42% to 4.56%). Table 2 shows the breakdown of these trends. However, progress towards total enrolment in Neno District exceeds the national average, and as of December 2015 Neno had enrolled 62.1% (n=7332 of n=11 800) of the expected total district population of persons living with HIV, while nationally this was 54.7% (n=563 203 of n=1 028 814) (P<0.001).
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Survival At baseline, 1-year survival among those in quarterly cohorts was 80.41% (P<0.001, 95% CI 79.22% to 81.59%) across facilities within districts. Comparatively, survival was 11.10% higher in Neno District, at 91.51% (P=0.002, 95% CI 4.13% to 18.07%). Between 2013 and 2015, survival rates declined by 1.75% (P<0.001, 95% CI −2.61% to −0.89%). This was not significantly different in Neno District (P=0.83, 95% CI −6.60% to 5.33%) (table 3) .
Retention
In 2013, 1-year retention among quarterly cohorts was 85.43% across all facilities within districts (P<0.001, 95% CI 84.2% to 86.62%). In Neno, this figure was 12.07% higher at 97.50% (P=0.001, 95% CI 5.08% to 19.05%). From 2013 to 2015, retention levels declined nationally by 2.92% (P<0.001, 95% CI −3.69% to −2.14%). This trend was similar in Neno (P=0.98, 95% CI −5.34% to 5.50%). Figure 1 provides an overview of results for survival and retention outcomes, and table 3 provides these outcomes by year.
dIsCussIon
We observed high total enrolment and 1-year survival and retention in care for ART-treated patients in Neno District, higher than all other districts nationally, suggesting the effectiveness of the Neno HIV programme across the HIV care continuum. These results were robust to secular trends and persisted over the entire BMJ Global Health 2013-2015 study period. While this study is not designed to estimate the relative impact of the components of our model, we postulate that a few unique aspects about the Neno HIV programme play critical roles in the results observed. First, the trained and paid cadre of CHWs enjoy low patient volume per CHW, allowing CHWs to do frequent routine-often daily-visits to support patient adherence, trace patients who missed visits, identify side effects or ill patients early, and flag any specific issues for the clinical staff. This is supported by literature advocating for CHWs for HIV programmes. 14 15 27 29 39 This CHW system is backed up by a robust standard operating procedure for missed visit tracking: CHWs make up the first tier, and when that fails HIV clinic staff go out on motorbikes on a weekly basis to locate patients and bring them back to clinic where possible.
Second, given the impoverished population served, we posit that our focus on addressing social determinants *Population is based on district-level population in 2014, the midpoint of the study, as reported by the Malawi National Statistics Office. 47 †Annual screenings represent the average annual number of the total HIV tests performed at facilities over the 2013-2015 study period in clients over age 15 years, expressed as a per cent of the district population over the age of 15. ‡Annual enrolment is the average annual newly enrolled in ART between 2013 and 2015, expressed as a per cent of those estimated to be HIV-positive within a district.
§One-year survival and retention indicates the average annual facility-level 1-year survival and retention rates for patients on ART within each district between 2013 and 2015.
BMJ Global Health of health is a critical piece, including the provision of food packages, cash transfers and inkind support to ART patients. Numerous studies support food packages as a means to optimising patient adherence. [19] [20] [21] Additionally, as governments work towards UHC, finding mechanisms to reduce catastrophic health expenditures is important, 4 with Neno District highlighting the use of social welfare interventions to mitigate the effects of poverty on our patients. Third, the approach in Neno District is characterised by the comprehensive spectrum of support by PIH, with a long-term commitment to key system inputs beyond technical assistance or capacity building. For example, as of 2016, PIH employs 34% of clinical staff doing direct care delivery and 66% of HIV programme staff, which has been consistent since 2013. 40 Other examples include construction and maintenance of hospitals and clinics, backstopping the MOH formulary with procurement of essential medications and health commodities, supporting an EMR and data quality improvement initiatives, and purchasing critical medical equipment for the district. This approach is informed by and echoes the sentiments put forward in the global arena, such as the Declaration of Alma Ata, advocating for primary healthcare and the 2005 Paris Declaration on Aid Effectiveness on aligning aid to countries' priorities and local systems. 41 42 We also describe favourable population-level uptake of HIV screening and ART linkage in Neno District. While the annual number of ART enrolments observed in Neno is consistent with national trends, Neno District is farther along towards achieving full programme enrolment. As districts in Malawi strive towards complete case finding, BMJ Global Health the yield of HIV testing in identifying new infections will decrease over time, and programmes will have to do more HIV testing and/or more targeted HIV testing to find new patients. These trends may have important considerations for programme design, in that traditionally 'high yield' has been a benchmarker for successful HIV testing programmes, but as countries move towards achieving the first 90, lower yields may in fact be a natural marker of success. This highlights the need for innovative and datadriven testing strategies to reach underserved PLHIV who
do not yet know their status and who are being missed by more traditional facility-based testing strategies. The approach in Neno has been to operationalise HIV testing as a standard screening test at the community, outpatient department and inpatient levels, which in 2015-2016 had yields of 1.9%, 2.9% and 3.8%, respectively. 43 In addition to striving towards universal opt-out, inpatient testing services, Neno employs a programme called Screening for Health And Referral in the Community, an integrated screening programme that targets the most remote areas of the district, sending teams out twice weekly to screen community members for HIV, tuberculosis, malnutrition, hypertension and diabetes. Although the yield is smaller, this blanket approach could be a critical part to reaching full enrolment. Early experience shows that 22.7% of community members screened at these events had never previously been tested. 44 The scalability and sustainability of this programme are contingent on a variety of factors. One of the most significant constraints is financing to support this model, as Malawi is one of the poorest countries in the world. 7 We have published elsewhere on the cost-effectiveness of this model, 45 showing that a quality-adjusted life year gained-on average-from the model costs less than BMJ Global Health three times the GDP per capita, a traditional marker of cost-effectiveness. 46 Beyond cost considerations are additional questions of scalability. In support of the scale-up enterprise, PIH has successfully expanded components of care models to regional and national levels in Rwanda 25 and Lesotho. 26 Findings reported in this study have also been presented to members of the parliament in Malawi, as well as members of the MOH. In the near term, our goal is to continue monitoring and demonstrating the success of this model and to engage in further health policy discussions.
There are a few key limitations to this study. First, district-level demographic covariates, such as age and gender distribution, were not included in the model as the analysis was done with national-level aggregate data, and HIV survival data were not disaggregated in Malawi by age and gender. Second, the outcomes do not map precisely on to the 90-90-90 targets, both because evaluating programmes by the first 90 without population-level data is challenging and because of the lack of complete viral load data for the district cohorts. As viral load testing becomes more routine and accessible, this will be a critical part of programme evaluation moving forward. We instead opted for a more practical and programme-oriented approach that uses robust proxy outcomes of survival and care retention to evaluate the programme and understand progress on themes of UHC and quality of care. Our analytical approach can be replicated in other resource-limited, high-burden settings to more regularly and rapidly assess HIV programme progress against national targets. Finally, given the retrospective nature of the data, as well as the utilisation of facility-level and district-level data instead of patient-level outcomes, we are limited in our ability to isolate the effect of certain programme components.
This study describes the results of an innovative model of district-wide partnership and HIV service delivery in Neno, demonstrating greater progress towards full HIV programme enrolment and higher 1-year patient retention and survival than national averages. Importantly, these effects have been maintained over at least a 3-year period. As governments strive towards meeting the 90-90-90 targets, we advocate for policies and practices (1) rooted in primary healthcare that tackle comprehensive and basic health system needs; (2) that leverage strong district-level partnership between non-governmental organisations and the public sector; (3) focused on strong community footprints; and 4) that pragmatically address the social determinants of health. Contributors EBW, NK and ELD conceptualised the study. ELD, RKM and AM provided data curation and expertise, and RKM led data analysis and methodology. EBW, NK, LD, CK and LN provided programme contextualisation. MH, JB and JR provided additional technical expertise. EBW and RKM prepared the first draft of the manuscript, and all authors edited and reviewed the manuscript.
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